Ninepoint Publishes 2026 Market Outlook

TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint”), one of Canada's leading independent investment management firms, today released its 2026 Market Outlook, outlining where its portfolio managers see the most compelling opportunities across key asset classes in the year ahead. The report features market insights spanning fixed income, global equities, energy, precious […]

Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC

(NasdaqGM:ISPO), DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today announced that it has entered into a definitive agreement to be acquired by Exclusive Investments LLC (“Exclusive Investments”), the parent company of Exclusive Resorts. Under the terms of the agreement, Exclusive Investments

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy

(NASDAQ:LGVN),(NASDAQ:LGVNR), The patent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to female patients with sexual dysfunction in order to increase sexual quality of life Female sexual dysfunction is an extremely common unmet medical need which can have a major impact on quality of life in otherwise healthy

SafeSpace Global Corporation (OTCID: SSGC) Appoints Harvest Communications as Investor Relations and Corporate Communications Consulting Agency

(Other OTC:SSGC),(OTC US:SSGC), Knoxville, TN, Dec. 17, 2025 (GLOBE NEWSWIRE) — SafeSpace Global Corporation (OTCID: SSGC), an AI technology company dedicated to protecting lives across education, healthcare, transportation, and correctional environments, today announced the appointment of Harvest Communications as its new investor relations (IR) and corporate communications consulting agency. This strategic partnership underscores SafeSpace Global's

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

(NASDAQ:CELZ), PHOENIX, Dec. 17, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company advancing regenerative medicine solutions, today announced the successful completion of patient enrollment in its FDA-cleared ADAPT clinical trial evaluating CELZ-201 (Olastrocel), the Company's proprietary perinatal tissue-derived cell therapy for the treatment of chronic lower back pain

Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC

Inspirato Announces Agreement to be Acquired by Exclusive Investments LLC GlobeNewswire December 17, 2025 DENVER, Dec. 17, 2025 (GLOBE NEWSWIRE) — Inspirato Incorporated (“Inspirato”) (Nasdaq: ISPO), the premier luxury vacation club and property technology company, today announced that it has entered into a definitive agreement to be acquired by Exclusive Investments LLC (“Exclusive Investments”), the

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy

Longeveron Granted U.S. Patent for Method of Treating Female Sexual Dysfunction Using its Proprietary Stem Cell Therapy GlobeNewswire December 17, 2025 The patent relates to methods of administering therapeutically effective amounts of isolated allogeneic mesenchymal stem cells (MSCs) to female patients with sexual dysfunction in order to increase sexual quality of life Female sexual dysfunction

SafeSpace Global Corporation (OTCID: SSGC) Appoints Harvest Communications as Investor Relations and Corporate Communications Consulting Agency

SafeSpace Global Corporation (OTCID: SSGC) Appoints Harvest Communications as Investor Relations and Corporate Communications Consulting Agency GlobeNewswire December 17, 2025 Knoxville, TN, Dec. 17, 2025 (GLOBE NEWSWIRE) — SafeSpace Global Corporation (OTCID: SSGC), an AI technology company dedicated to protecting lives across education, healthcare, transportation, and correctional environments, today announced the appointment of Harvest Communications

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point

Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point Completion of Enrollment Positions CELZ for Near-Term Data Catalysts and Accelerates Path Toward Commercialization of a Transformative, Non-Opioid Therapy for Chronic Lower Back Pain GlobeNewswire December 17, 2025 PHOENIX, Dec. 17, 2025 (GLOBE NEWSWIRE) — Creative Medical

Ninepoint Publishes 2026 Market Outlook

Ninepoint Publishes 2026 Market Outlook GlobeNewswire December 17, 2025 TORONTO, Dec. 17, 2025 (GLOBE NEWSWIRE) — Ninepoint Partners LP (“Ninepoint”), one of Canada's leading independent investment management firms, today released its 2026 Market Outlook, outlining where its portfolio managers see the most compelling opportunities across key asset classes in the year ahead. The report features

Scroll to Top